Indaptus Therapeutics, Inc. raised approximately $3.4 million through a private placement on June 30, 2025, bringing total proceeds from recent funding to about $5.7 million, intended for clinical trial and general corporate use. This follows an earlier placement of $2.3 million completed on June 12, 2025.